Haiyan Xu

Efficacy and Safety of the 3-Month Formulation of Paliperidone Palmitate vs Placebo for Relapse Prevention of Schizophrenia

Joris Berwaerts, Yanning Liu, Srihari Gopal et al. · JAMA Psychiatry · 2015 · 193 citations

Efficacy and Safety of Paliperidone Palmitate 3-Month Formulation for Patients with Schizophrenia: A Randomized, Multicenter, Double-Blind, Noninferiority Study

Adam Savitz, Haiyan Xu, Srihari Gopal et al. · The International Journal of Neuropsychopharmacology · 2016 · 159 citations · Full text

Efficacy and safety of paliperidone palmitate in adult patients with acutely symptomatic schizophrenia: a randomized, double-blind, placebo-controlled, dose-response study

Srihari Gopal, David Hough, Haiyan Xu et al. · International Clinical Psychopharmacology · 2010 · 153 citations

Palmitate 50, Paliperidone Palmitate, Psychiatry +13

CRISPR/Cas9 facilitates investigation of neural circuit disease using human iPSCs: mechanism of epilepsy caused by an SCN1A loss-of-function mutation

Jianche Liu, Caixia Gao, Wenli Chen et al. · Translational Psychiatry · 2016 · 96 citations · Full text

Neurogenomics, Synaptic Transmission, Neural Circuit Disease +25

A comparative study of paliperidone palmitate and risperidone long-acting injectable therapy in schizophrenia

Huafang Li, Qing Rui, Xiaoping Ning et al. · Progress in Neuro-Psychopharmacology and Biological Psychiatry · 2011 · 91 citations

Paliperidone Palmitate, Psychiatry, Psychotic Disorder +11